Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03667599 · ClinicalTrials.gov registry record · NA
A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
A NA study of Well-being of Caregivers (Caregiver Strain Index), sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03667599 is a NA study of Well-being of Caregivers (Caregiver Strain Index) that is actively recruiting participants, run by Duke University. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03667599, a NA study of Well-being of Caregivers (Caregiver Strain Index), is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
Conditions Studied
Interventions
- OTHER home care
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-09-28 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03667599
The ClinicalTrials.gov registry entry for NCT03667599 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Well-being of Caregivers (Caregiver Strain Index) appearing as the primary indexed condition, and to 1 intervention - of which home care is the first listed.
NCT03667599 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03667599 about?
NCT03667599 is a clinical study titled "A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation". This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
What is the current status of trial NCT03667599?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2018-09-28. Estimated completion is 2027-01-30.
What conditions does trial NCT03667599 study?
This clinical trial studies the following conditions: Well-being of Caregivers (Caregiver Strain Index).
What interventions are being tested in trial NCT03667599?
The interventions under investigation include: home care (OTHER).
Who is sponsoring clinical trial NCT03667599?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03667599 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.